Categories
IP - In Person
DateApril 19, 2023There are several drivers behind the need for process improvements and innovation in the CMC bioassay space. Most organizations experience a constant pressure to reduce cost, increase throughput, and be more efficient…Session Chairs
Speakers
DateApril 19, 2023Cell and Gene Therapies (CGT) are transforming not just how humans treat genetic and intractable diseases but are altering the entire pharmaceutical ecosystem…Session Chairs
Speaker
DateApril 18, 2023Bioassays are one of the more complex assays used to support therapeutic product development. As such, the practical elements of bioassays (the “nuts and bolts”) can also be complex. These elements can range from the critical reagents selected for use in the bioassay (e.g…
DateApril 19, 2023Session Chairs
DateApril 18, 2023Helena Madden, bluebird bio, Inc…Session Chairs
DateApril 17, 2024MEANINGFUL BIOASSAYS TO ELUCIDATE STRUCTURE-FUNCTION AND DEMONSTRATE CONTROLSession Chairs
DateApril 17, 2024QUANTIFYING ENDOGENOUS PROTEIN CONTENT TO MEASURE AND CONTROL POTENCY OF ANTIBODY-PROTAC CONJUGATES
DateApril 16, 2024LESSONS LEARNED FOR POTENCY ASSAYS FOR BISPECIFIC MABS FOR ACCELERATED PROGRAMS
DateApril 16, 2024Welcome to Bioassays 2024, thank you for joining us!Session Chair
Speaker
Dean Smith, PhDHealth Canada
